{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T06:28:14Z","timestamp":1787120894771,"version":"build-2736575974"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>\n                    Clinically used opioids, such as morphine, primarily act through the\n                    <jats:italic>\u03bc<\/jats:italic>\n                    -opioid receptor (MOR), encoded by the\n                    <jats:italic>OPRM1<\/jats:italic>\n                    gene, which undergoes extensive alternative splicing. More than 20\n                    <jats:italic>OPRM1<\/jats:italic>\n                    isoforms have been identified, yet functional characterization has largely focused on the canonical MOR-1 variant. With the emergence of three-dimensional human cerebral organoids (hCOs) derived from induced pluripotent stem cells (iPSCs), it is now possible to model human-specific neuronal responses to opioids more accurately. In this study, we established hCOs as a functional platform to investigate the impact of morphine on\n                    <jats:italic>OPRM1<\/jats:italic>\n                    pre-mRNA splicing and opioid signaling. We generated iPSC-derived hCOs and neurons, after which they were treated with or without morphine and screened using cellular and molecular\/biochemical assays. Our results revealed that morphine exposure selectively induced the MOR-1X isoform in hCOs and iPSC-derived neurons in a dose-dependent manner as revealed by RT-PCR and RT-qPCR. We utilized CRE\/CREB overexpression plasmid and lentiviral constructs to measure effects of morphine on cyclic AMP (cAMP) signaling. Upon morphine withdrawal, cells expressing MOR-1X exhibited markedly enhanced cAMP superactivation, a molecular hallmark of opioid dependence, compared with MOR-1. Furthermore, isoform-specific knockdown of MOR-1X by a short hairpin RNA (shRNA) effectively abolished this cAMP overshoot in iPSC-derived neurons. Collectively, these findings identify MOR-1X as a morphine-inducible isoform with a potential key role in the molecular mechanisms underlying opioid signaling, adaptation, and dependence in the brain.\n                  <\/jats:p>","DOI":"10.3389\/fnins.2026.1907881","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T05:49:07Z","timestamp":1787118547000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Morphine-induced \u03bc-opioid receptor isoform MOR-1X amplifies dependence-related signaling"],"prefix":"10.3389","volume":"20","author":[{"given":"Michael","family":"Swingler","sequence":"first","affiliation":[{"name":"Department of Microbiology, Immunology, and Inflammation, Center for Neurovirology and Gene Editing, Temple University Lewis Katz School of Medicine","place":["Philadelphia, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Donadoni","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology, and Inflammation, Center for Neurovirology and Gene Editing, Temple University Lewis Katz School of Medicine","place":["Philadelphia, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senem","family":"Cakir","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology, and Inflammation, Center for Neurovirology and Gene Editing, Temple University Lewis Katz School of Medicine","place":["Philadelphia, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed","family":"Bishir","sequence":"additional","affiliation":[{"name":"Institute of NeuroImmune Pharmacology, Seton Hall University","place":["South Orange, NJ, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfei","family":"Huang","sequence":"additional","affiliation":[{"name":"Institute of NeuroImmune Pharmacology, Seton Hall University","place":["South Orange, NJ, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulie L.","family":"Chang","sequence":"additional","affiliation":[{"name":"Institute of NeuroImmune Pharmacology, Seton Hall University","place":["South Orange, NJ, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilker K.","family":"Sariyer","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology, and Inflammation, Center for Neurovirology and Gene Editing, Temple University Lewis Katz School of Medicine","place":["Philadelphia, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"3779","DOI":"10.3390\/ijms22073779","article-title":"Endogenous opioid peptides and alternatively spliced mu opioid receptor seven transmembrane carboxyl-terminal variants","volume":"22","author":"Abrimian","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1097\/ALN.0b013e318238bba6","article-title":"Molecular mechanisms of opioid receptor-dependent signaling and behavior","volume":"115","author":"Al-Hasani","year":"2011","journal-title":"Anesthesiology"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"102282","DOI":"10.1016\/j.omtn.2024.102282","article-title":"Suppression of HSV-1 infection and viral reactivation by CRISPR-Cas9 gene editing in 2D and 3D culture models","volume":"35","author":"Bellizzi","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"3824","DOI":"10.1523\/JNEUROSCI.5010-04.2005","article-title":"cAMP-mediated mechanisms for pain sensitization during opioid withdrawal","volume":"25","author":"Bie","year":"2005","journal-title":"J. Neurosci."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41580-024-00804-1","article-title":"Modelling human brain development and disease with organoids","volume":"26","author":"Birtele","year":"2025","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1002\/pmic.200300771","article-title":"Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence","volume":"4","author":"Blom","year":"2004","journal-title":"Proteomics"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/jnr.24640","article-title":"Dysregulated expression of the alternatively spliced variant mRNAs of the mu opioid receptor gene, OPRM1, in the medial prefrontal cortex of male human heroin abusers and heroin self-administering male rats","volume":"100","author":"Brown","year":"2022","journal-title":"J. Neurosci. Res."},{"key":"ref8","year":"2025"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/jnc.14863","article-title":"Phosphorylation of unique C-terminal sites of the mu-opioid receptor variants 1B2 and 1C1 influences their Gs association following chronic morphine","volume":"152","author":"Chakrabarti","year":"2020","journal-title":"J. Neurochem."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"837","DOI":"10.4103\/NRR.NRR-D-24-01639","article-title":"Human cerebral organoids: complex, versatile, and human-relevant models of neural development and brain diseases","volume":"21","author":"Coronel","year":"2025","journal-title":"Neural Regen. Res."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s13365-024-01204-z","article-title":"Modeling HIV-1 infection and NeuroHIV in hiPSCs-derived cerebral organoid cultures","volume":"30","author":"Donadoni","year":"2024","journal-title":"J. Neurovirol."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41419-019-1673-3","article-title":"Alcohol exposure alters pre-mRNA splicing of antiapoptotic mcl-1L isoform and induces apoptosis in neural progenitors and immature neurons","volume":"10","author":"Donadoni","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s11481-021-10009-4","article-title":"Modulation of OPRM1 alternative splicing by morphine and HIV\u20131 Nef","volume":"17","author":"Donadoni","year":"2022","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"567","DOI":"10.15585\/mmwr.mm7325a1","article-title":"Treatment for opioid use disorder: population estimates \u2014 United States, 2022","volume":"73","author":"Dowell","year":"2024","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"ref15","author":"Dydyk","year":"2025"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"12774","DOI":"10.1074\/jbc.M009571200","article-title":"Phosphorylation of Ser363, Thr370, and Ser375 residues within the carboxyl tail differentially regulates mu-opioid receptor internalization","volume":"276","author":"El Kouhen","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1089\/scd.2022.0116","article-title":"Cerebral organoids to study central mechanisms of pain: the effect of stem cell Secretome on opioid receptors and neuroplasticity","volume":"31","author":"Fernandes","year":"2022","journal-title":"Stem Cells Dev."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1744-8069-6-33","article-title":"A novel alternatively spliced isoform of the mu-opioid receptor: functional antagonism","volume":"6","author":"Gris","year":"2010","journal-title":"Mol. Pain"},{"key":"ref19","author":"Herman","year":"2024"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41380-022-01837-8","article-title":"Single cell transcriptomics reveals distinct transcriptional responses to oxycodone and buprenorphine by iPSC-derived brain organoids from patients with opioid use disorder","volume":"29","author":"Ho","year":"2024","journal-title":"Mol. Psychiatry"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e2400847","DOI":"10.1002\/advs.202400847","article-title":"Chronic opioid treatment arrests neurodevelopment and alters synaptic activity in human midbrain organoids","volume":"11","author":"Kim","year":"2024","journal-title":"Adv. Sci."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.1111\/bph.70417","article-title":"Inhibition of adenylyl cyclase 1 or exchange protein activated by cAMP restores ATP-sensitive potassium channel activity after chronic opioid exposure","volume":"183","author":"Klein","year":"2026","journal-title":"Br. J. Pharmacol."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"31408","DOI":"10.1074\/jbc.M100305200","article-title":"C-terminal splice variants of the mouse mu-opioid receptor differ in morphine-induced internalization and receptor resensitization","volume":"276","author":"Koch","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1151\/spp021113","article-title":"The neurobiology of opioid dependence: implications for treatment","volume":"1","author":"Kosten","year":"2002","journal-title":"Sci. Pract. Perspect."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nature12517","article-title":"Cerebral organoids model human brain development and microcephaly","volume":"501","author":"Lancaster","year":"2013","journal-title":"Nature"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.3390\/biom11101525","article-title":"Alternative pre-mRNA splicing of the mu opioid receptor gene, OPRM1: insight into complex mu opioid actions","volume":"11","author":"Liu","year":"2021","journal-title":"Biomolecules"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13619-021-00103-6","article-title":"Modeling human neurodevelopmental diseases with brain organoids","volume":"11","author":"Lu","year":"2022","journal-title":"Cell Regen."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/s0376-8716(00)00181-2","article-title":"Opioids, opioid receptors, and the immune response","volume":"62","author":"McCarthy","year":"2001","journal-title":"Drug Alcohol Depend."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.cell.2006.01.040","article-title":"A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen","volume":"124","author":"Moffat","year":"2006","journal-title":"Cell"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.celrep.2019.09.034","article-title":"Allostatic changes in the cAMP system drive opioid-induced adaptation in striatal dopamine signaling","volume":"29","author":"Muntean","year":"2019","journal-title":"Cell Rep."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"136","DOI":"10.9758\/cpn.2012.10.3.136","article-title":"Transcriptional mechanisms of drug addiction","volume":"10","author":"Nestler","year":"2012","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1126\/science.278.5335.58","article-title":"Molecular and cellular basis of addiction","volume":"278","author":"Nestler","year":"1997","journal-title":"Science"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1124\/mol.56.2.396","article-title":"Identification and characterization of three new alternatively spliced mu-opioid receptor isoforms","volume":"56","author":"Pan","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.neuroscience.2004.12.033","article-title":"Identification and characterization of six new alternatively spliced variants of the human mu opioid receptor gene, Oprm","volume":"133","author":"Pan","year":"2005","journal-title":"Neuroscience"},{"key":"ref35","first-page":"89","volume-title":"Substance Use Disorders: From Etiology to Treatment","author":"Pasternak","year":"2020"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1124\/pr.112.007138","article-title":"Mu opioids and their receptors: evolution of a concept","volume":"65","author":"Pasternak","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/npp.2014.272","article-title":"Effects of the mu opioid receptor polymorphism (OPRM1 A118G) on pain regulation, placebo effects and associated personality trait measures","volume":"40","author":"Peci\u00f1a","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s10571-020-00971-7","article-title":"Alternative splicing of opioid receptor genes shows a conserved pattern for 6TM receptor variants","volume":"41","author":"Piltonen","year":"2021","journal-title":"Cell. Mol. Neurobiol."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1111\/bph.13750","article-title":"Opioids and the immune system - friend or foe","volume":"175","author":"Plein","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1002\/jcp.25246","article-title":"Morphine-induced MOR-1X and ASF\/SF2 expressions are independent of transcriptional regulation: implications for MOR-1X signaling","volume":"231","author":"Regan","year":"2016","journal-title":"J. Cell. Physiol."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1073\/pnas.72.8.3092","article-title":"Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance","volume":"72","author":"Sharma","year":"","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1073\/pnas.74.8.3365","article-title":"Opiate-dependent modulation of adenylate cyclase","volume":"74","author":"Sharma","year":"1977","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1073\/pnas.72.2.590","article-title":"Morphine receptors as regulators of adenylate cyclase activity","volume":"72","author":"Sharma","year":"","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.2741\/3306","article-title":"The evolution of vertebrate opioid receptors","volume":"14","author":"Stevens","year":"2009","journal-title":"Front. Biosci."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1261\/rna.2192803","article-title":"Lentivirus-delivered stable gene silencing by RNAi in primary cells","volume":"9","author":"Stewart","year":"2003","journal-title":"RNA N. Y."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/s42003-023-05582-8","article-title":"Functional brain region-specific neural spheroids for modeling neurological diseases and therapeutics screening","volume":"6","author":"Strong","year":"2023","journal-title":"Commun. Biol."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1597922","DOI":"10.3389\/fnins.2025.1597922","article-title":"Molecular and cellular basis of mu-opioid receptor signaling: mechanisms underlying tolerance and dependence development","volume":"19","author":"Swingler","year":"2025","journal-title":"Front. Neurosci."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1038\/s41386-018-0225-3","article-title":"Untangling the complexity of opioid receptor function","volume":"43","author":"Valentino","year":"2018","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"108161","DOI":"10.1016\/j.pharmthera.2022.108161","article-title":"In vitro functional assays as a tool to study new synthetic opioids at the \u03bc-opioid receptor: potential, pitfalls and progress","volume":"235","author":"Vandeputte","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41380-020-0661-4","article-title":"The changing opioid crisis: development, challenges and opportunities","volume":"26","author":"Volkow","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.brainresrev.2007.06.006","article-title":"\u201cListening\u201d and \u201ctalking\u201d to neurons: implications of immune activation for pain control and increasing the efficacy of opioids","volume":"56","author":"Watkins","year":"2007","journal-title":"Brain Res. Rev."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1124\/pr.112.005942","article-title":"Regulation of \u03bc-opioid receptors: desensitization, phosphorylation, internalization, and tolerance","volume":"65","author":"Williams","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s10571-011-9689-y","article-title":"Inhibition of morphine-induced cAMP overshoot: a cell-based assay model in a high-throughput format","volume":"31","author":"Xia","year":"2011","journal-title":"Cell. Mol. Neurobiol."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s43586-022-00174-y","article-title":"Organoids","volume":"2","author":"Zhao","year":"2022","journal-title":"Nat. Rev. Methods Primers"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2026.1907881\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T05:49:08Z","timestamp":1787118548000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2026.1907881\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":54,"alternative-id":["10.3389\/fnins.2026.1907881"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2026.1907881","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]},"article-number":"1907881"}}